VOYA Investment Management
VRDN icon

VOYA Investment Management’s Viridian Therapeutics VRDN Stock Holding History

VOYA Investment Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.59M Sell
249,763
-12,254
-5% -$197K ﹤0.01% 901
2026
Q1 		$5.13M Buy
262,017
+248,256
+1,804% +$7.37M 0.01% 821
2025
Q4 		$428K Buy
13,761
+970
+8% +$26.6K ﹤0.01% 1822
2025
Q3 		$276K Sell
12,791
-7,221
-36% -$130K ﹤0.01% 2030
2025
Q2 		$280K Buy
20,012
+242
+1% +$3.28K ﹤0.01% 2183
2025
Q1 		$267K Sell
19,770
-1,627
-8% -$27.7K ﹤0.01% 2176
2024
Q4 		$410K Buy
21,397
+1,038
+5% +$22.6K ﹤0.01% 2026
2024
Q3 		$463K Sell
20,359
-591
-3% -$9.66K ﹤0.01% 2035
2024
Q2 		$273K Buy
20,950
+5,965
+40% +$82.6K ﹤0.01% 2300
2024
Q1 		$262K Sell
14,985
-1,697
-10% -$32.9K ﹤0.01% 2321
2023
Q4 		$363K Sell
16,682
-370
-2% -$5.84K ﹤0.01% 2236
2023
Q3 		$262K Buy
17,052
+297
+2% +$5.67K ﹤0.01% 2381
2023
Q2 		$399K Buy
16,755
+2,458
+17% +$63K ﹤0.01% 2210
2023
Q1 		$364K Hold
14,297
– – ﹤0.01% 2222
2022
Q4 		$418K Buy
14,297
+3,877
+37% +$89.3K ﹤0.01% 2130
2022
Q3 		$214K Buy
+10,420
New +$187K ﹤0.01% 2567
2019
Q2 		– Sell
-703
Closed -$29K – 2617
2019
Q1 		$29K Hold
703
– – ﹤0.01% 2532
2018
Q4 		$32K Hold
703
– – ﹤0.01% 2522
2018
Q3 		$59K Hold
703
– – ﹤0.01% 2556
2018
Q2 		$68K Buy
+703
New +$74.3K ﹤0.01% 2578

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

VOYA Investment Management's VRDN Position: Q2 2026 in Review

VOYA Investment Management reduced its Viridian Therapeutics (VRDN) stake by 4.7% in Q2 2026, selling an estimated $197K and leaving 249,763 shares worth $4.59M. The position accounts for ﹤0.01% of the portfolio, ranked #901.

VOYA Investment Management first reported a position in VRDN in Q2 2018 and has held it in 20 quarters since. The position peaked at $5.13M in Q1 2026. 212 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • VOYA Investment Management held 249,763 shares of Viridian Therapeutics worth $4.59M as of Q2 2026.
  • VOYA Investment Management sold 12,254 Viridian Therapeutics shares in Q2 2026, an estimated $197K.
  • Viridian Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #901 holding.
  • VOYA Investment Management first reported a position in Viridian Therapeutics in Q2 2018 and has held it in 20 quarters since.
  • VOYA Investment Management's Viridian Therapeutics position peaked at $5.13M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.